Gilead Sciences to Present at Upcoming Investor Conference
21 Dezembro 2023 - 6:05PM
Business Wire
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its
executives will be speaking at the following investor
conference:
J.P. Morgan Healthcare Conference on Monday,
January 8, 2024 beginning at 10:30 a.m. Pacific Time
The live webcast can be accessed at the company’s investors page
at investors.gilead.com. The replay will be available for at least
30 days following the presentation.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has
pursued and achieved breakthroughs in medicine for more than three
decades, with the goal of creating a healthier world for all
people. The company is committed to advancing innovative medicines
to prevent and treat life-threatening diseases, including HIV,
viral hepatitis and cancer. Gilead operates in more than 35
countries worldwide, with headquarters in Foster City,
California.
For more information on Gilead Sciences, please visit the
company’s website at www.gilead.com, follow Gilead on Twitter
(@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5
or 1-650-574-3000.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231221812128/en/
Jacquie Ross, Investors Investor_relations@gilead.com
Gilead Sciences (NASDAQ:GILD)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Gilead Sciences (NASDAQ:GILD)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024
